LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c‐Myc mRNA stability

BACKGROUND: Chemoresistance to cisplatin (DDP) remains a major challenge in advanced gastric cancer (GC) treatment. Although accumulating evidence suggests an association between dysregulation of long non‐coding RNAs (lncRNAs) and chemoresistance, the regulatory functions and complexities of lncRNAs...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yiran, Zhou, Bingluo, Hu, Xinyang, Ying, Shilong, Zhou, Qiyin, Xu, Wenxia, Feng, Lifeng, Hou, Tianlun, Wang, Xian, Zhu, Liyuan, Jin, Hongchuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785984/
https://www.ncbi.nlm.nih.gov/pubmed/35073459
http://dx.doi.org/10.1002/ctm2.703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785984/
https://www.ncbi.nlm.nih.gov/pubmed/35073459
http://dx.doi.org/10.1002/ctm2.703

Ejemplares similares